Literature DB >> 26198058

MiR-23b and miR-199a impair epithelial-to-mesenchymal transition during atrioventricular endocardial cushion formation.

Fernando Bonet1, Ángel Dueñas1, Carmen López-Sánchez2, Virginio García-Martínez2, Amelia E Aránega1, Diego Franco1.   

Abstract

BACKGROUND: Valve development is a multistep process involving the activation of the cardiac endothelium, epithelial-mesenchymal transition (EMT) and the progressive alignment and differentiation of distinct mesenchymal cell types. Several pathways such as Notch/delta, Tgf-beta and/or Vegf signaling have been implicated in crucial steps of valvulogenesis. We have previously demonstrated discrete changes in microRNAs expression during cardiogenesis, which are predicted to target Bmp- and Tgf-beta signaling. We now analyzed the expression profile of 20 candidate microRNAs in atrial, ventricular, and atrioventricular canal regions at four different developmental stages.
RESULTS: qRT-PCR analyses of microRNAs demonstrated a highly dynamic and distinct expression profiles within the atrial, ventricular, and atrioventricular canal regions of the developing chick heart. miR-23b, miR-199a, and miR-15a displayed increased expression during early AVC development whereas others such as miR-130a and miR-200a display decreased expression levels. Functional analyses of miR-23b, miR-199a, and miR-15a overexpression led to in vitro EMT blockage. Molecular analyses demonstrate that distinct EMT signaling pathways are impaired after microRNA expression, including a large subset of EMT-related genes that are predicted to be targeted by these microRNAs.
CONCLUSIONS: Our data demonstrate that miR-23b and miR-199a over-expression can impair atrioventricular EMT.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  EMT; cardiac valve development; miR-199a; miR-23b

Mesh:

Substances:

Year:  2015        PMID: 26198058     DOI: 10.1002/dvdy.24309

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  16 in total

Review 1.  Making a heart: advances in understanding the mechanisms of cardiac development.

Authors:  Ellen Dees; H Scott Baldwin
Journal:  Curr Opin Pediatr       Date:  2016-10       Impact factor: 2.856

2.  miR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting Slug.

Authors:  Zhihao Wu; Xiangli Li; Xuehong Cai; Chenggang Huang; Min Zheng
Journal:  Tumour Biol       Date:  2015-12-23

Review 3.  The Early Stages of Heart Development: Insights from Chicken Embryos.

Authors:  Johannes G Wittig; Andrea Münsterberg
Journal:  J Cardiovasc Dev Dis       Date:  2016-04-05

Review 4.  More than Just a Simple Cardiac Envelope; Cellular Contributions of the Epicardium.

Authors:  Angel Dueñas; Amelia E Aranega; Diego Franco
Journal:  Front Cell Dev Biol       Date:  2017-05-01

Review 5.  Functional Role of Non-Coding RNAs during Epithelial-To-Mesenchymal Transition.

Authors:  Almudena Expósito-Villén; Amelia E Aránega; Diego Franco
Journal:  Noncoding RNA       Date:  2018-05-28

6.  miTALOS v2: Analyzing Tissue Specific microRNA Function.

Authors:  Martin Preusse; Fabian J Theis; Nikola S Mueller
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

Review 7.  Endothelial-Mesenchymal Transition in Regenerative Medicine.

Authors:  Damian Medici
Journal:  Stem Cells Int       Date:  2016-04-07       Impact factor: 5.443

Review 8.  Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches.

Authors:  Emenike K Onyido; Eloise Sweeney; Abdolrahman Shams Nateri
Journal:  Mol Cancer       Date:  2016-09-02       Impact factor: 27.401

Review 9.  The therapeutic potential of targeting the endothelial-to-mesenchymal transition.

Authors:  Shirley Man; Gonzalo Sanchez Duffhues; Peter Ten Dijke; David Baker
Journal:  Angiogenesis       Date:  2018-08-03       Impact factor: 9.596

Review 10.  Non-coding RNA in endothelial-to-mesenchymal transition.

Authors:  Melanie S Hulshoff; Gonzalo Del Monte-Nieto; Jason Kovacic; Guido Krenning
Journal:  Cardiovasc Res       Date:  2019-10-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.